Wall Street 1/11/13 Lazard Raises CELG to $123, Accelerating Growth. // link //
By Deann Marin | More Articles
January 11, 2013
Page 4 of 5
Celgene Corporation (NASDAQ:CELG): Current price $82.3716
After the company issued guidance earlier this week, Lazard Capital raised their price target for Celgene Corporation and noted accelerating growth prospects. The firm calls Celgene one of their top picks for 2013 and keeps a Buy rating on the name.